Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials

Episode von Medizin - Open Access LMU - Teil 15/22 von Ludwig-Maximilians-Universität München · 1. Januar 2007

Background: Recent reviews on placebo effects in clinical trials suggest that objective changes following placebo treatments may not exist or, at least, have been considerably overestimated. However, the possibility that yet unidentified subsets of parameters are responsive to placebo treatments has not been taken into account. Therefore, the aim of the present study is to examine the effects of placebo treatments on objectively measured outcome parameters by specifically focusing on peripheral disease processes. Methods: An initial dataset was collected from a MEDLINE search for placebo-controlled, randomized clinical trials. Trials with stable disease conditions were identified, and the effects of placebo treatments on peripheral outcome parameters were estimated by the changes from baseline in the placebo groups. An explorative data analysis was conducted in order to identify parameter classes with differential responsiveness to placebo treatments. A subgroup meta-analysis of a second dataset was performed to test whether the preliminary classification would also apply to placebo effects derived from the comparison of placebo groups with untreated control groups. Results: The explorative analysis of outcome parameters and strength of placebo effects yielded a classification into responsive "physical" versus non-responsive "biochemical" parameters. In total, 50% of trials measuring physical parameters showed significant placebo effects, compared with 6% of trials measuring biochemical parameters. A subgroup meta-analysis substantiated the differential response ( physical parameters: n = 14, Hedges' pooled effect size g = 0.34, 95% CI 0.22 to 0.46; biochemical parameters: n = 15, g = 0.03, 95% CI - 0.04 to 0.10). The subanalysis of the second dataset supported the classification and revealed a significant improvement for physical parameters ( n = 20, g = 0.22, 95% CI 0.07 to 0.36) and a deterioration for biochemical parameters ( n = 6, g = - 0.17, 95% CI - 0.31 to - 0.02). Conclusion: The results suggest that placebo interventions can improve physical disease processes of peripheral organs more easily and effectively than biochemical processes. This differential response offers a good starting point for theoretical considerations on possible mediating mechanisms, and for future investigations in this field.

Weitere Episoden von „Medizin - Open Access LMU - Teil 15/22“

• Occupation and adult onset of rhinitis in the general population 1. Januar 2008
• Retention of mouth-to-mouth, mouth-to-mask and mouth-to-face shield ventilation 1. Januar 2008
• An in vivo evaluation of Brilliant Blue G in animals and humans 1. Januar 2008
• Syk-mediated translocation of PI3Kδ to the leading edge controls lamellipodium formation and migration of leukocytes 7. November 2007
• Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor 1. Oktober 2007
• Natural killer cells promote early CD8 T cell responses against cytomegalovirus. 24. August 2007
• Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome 23. Mai 2007
• The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts 1. April 2007
• Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system 1. März 2007
• Antithrombin and hypercoagulability in sepsis: insights from thrombelastography? 1. Januar 2007
• Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study 1. Januar 2007
• Does respiratory health contribute to the effects of long-term air pollution exposure on cardiovascular mortality? 1. Januar 2007
• Acute childhood diarrhoea in northern Ghana: epidemiological, clinical and microbiological characteristics 1. Januar 2007
• Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent 1. Januar 2007
• Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant 1. Januar 2007

Alle Episoden von Medizin - Open Access LMU - Teil 15/22 · Mehr Bildung-Podcasts